Related references
Note: Only part of the references are listed.Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy
Marielle J. van Breemen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Fabry disease
Dominique P. Germain
ORPHANET JOURNAL OF RARE DISEASES (2010)
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
Johannes M. Aerts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Fabry disease and the skin: data from FOS, the Fabry outcome survey
C. H. Orteu et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Clinical manifestations of Fabry disease in children: Data from the Fabry outcome survey
U Ramaswami et al.
ACTA PAEDIATRICA (2006)
Effect of genetic modifiers on cerebral lesions in Fabry disease
G Altarescu et al.
NEUROLOGY (2005)
The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy
C Whybra et al.
CLINICAL GENETICS (2004)
Remarkable variability in renal disease in a large Slovenian family with Fabry disease
F Verovnik et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2004)
Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers
A Morrone et al.
JOURNAL OF MEDICAL GENETICS (2003)
Endothelial nitric oxide synthase gene polymorphisms in Fabry's disease
C Heltianu et al.
CLINICAL GENETICS (2002)
Identification of fifteen novel mutations and genotype-phenotype relationship in Fabry disease
GM Altarescu et al.
CLINICAL GENETICS (2001)
Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease.
CM Eng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Enzyme replacement therapy in Fabry disease - A randomized controlled trial
R Schiffmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases?
I Maire
JOURNAL OF INHERITED METABOLIC DISEASE (2001)
Characterization of two α-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease
R Kase et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2000)
Share Paper
